Current Applications of Polycaprolactone as a Scaffold Material for Heart Regeneration

Phillip R Schmitt1, Kiera D Dwyer1, Kareen L K Coulombe1

  • 1Center for Biomedical Engineering, School of Engineering, Brown University, Providence, Rhode Island 02912, United States.

Insights

Polycaprolactone (PCL) scaffolds show promise for regenerating heart tissue after injury. These biodegradable materials mimic native heart mechanics, aiding in engineered myocardium repair and function restoration.

Area of Science:

  • Biomaterials Science
  • Cardiovascular Engineering
  • Regenerative Medicine

Background:

  • Heart failure (HF) is a leading global cause of death, often resulting from cardiomyocyte loss.
  • Cardiac tissue engineering offers a strategy to regenerate contractile tissue and restore heart function.
  • Current engineered tissues struggle to replicate the native heart's mechanical strength and structural organization.

Purpose of the Study:

  • To review the application of polycaprolactone (PCL) as a scaffold for myocardium repair and regeneration.
  • To outline PCL fabrication approaches, properties, and potential in engineered myocardium.
  • To suggest future directions for clinical translation of PCL-based cardiac regeneration.

Main Methods:

  • Literature review focusing on PCL scaffolds in cardiac tissue engineering.
  • Analysis of PCL's mechanical, chemical, and biocompatible properties relevant to cardiac repair.
  • Examination of fabrication techniques for PCL scaffolds in myocardial regeneration.

Main Results:

  • PCL exhibits desirable properties for cardiac scaffolds, including facile fabrication and biodegradability.
  • PCL scaffolds can potentially mimic the native heart's mechanical and structural environment.
  • PCL offers a promising material for regenerating contractile tissue and improving engineered myocardium function.

Conclusions:

  • Polycaprolactone is a viable material for developing cardiac tissue engineering scaffolds.
  • Further research into PCL fabrication and its integration into engineered myocardium is warranted.
  • PCL-based strategies hold potential for clinical translation in heart repair and regeneration.

Related Concept Videos